SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]
SEC Accession No. 0001354457-24-000131
Filing Date
2024-03-07
Accepted
2024-03-07 09:46:09
Documents
2
Effectiveness Date
2024-03-07

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE/A  
1 primary_doc.xml 25-NSE/A 1082
2 amam-form25.txt EX-99.25 109
  Complete submission text file 0001354457-24-000131.txt   3084
Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE/A

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Subject) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
Type: 25-NSE/A | Act: 34 | File No.: 000-56600 | Film No.: 24728393
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)